Back

EMPEROR-Preserved - Discussant review.

27 August 2021 (17:37 - 17:42)
Organised by:
Congress Presentation Part of: Hot Line - EMPEROR-Preserved / EMPEROR-Pooled Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Frank Ruschitzka

University Hospital Zurich, Zurich (Switzerland)

4 More presentations in this session

Presentation thumbnail
EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalisations in patients with heart failure with a preserved ejection fraction, with and without diabetes
Professor S. Anker (Berlin, DE)
Slides Video
Presentation thumbnail
EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis
Professor M. Packer (Dallas, US)
Slides Video
Presentation thumbnail
EMPEROR-Pooled - Discussant review.
Professor R. De Boer (Rotterdam, NL)
Slides Video
Presentation thumbnail
EMPEROR-Preserved / EMPEROR-Pooled - Panel discussion.

Access the full session

Session thumbnail
Hot Line - EMPEROR-Preserved / EMPEROR-Pooled
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 17:37 CET
You may be interested in
thumbnail
Congress Presentation
EMPEROR - Empagliflozin in Patients with Chronic Heart Failure
25 August 2023
thumbnail
Congress Session
Acute aortic dissection: a fantastic voyage through imaging
25 August 2023
thumbnail
Congress Presentation
Discussant review - PRAISE-HFpEF DM
12 May 2024
thumbnail
Congress Presentation
Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: Long-term outcomes from the PRESERVE EF study
13 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources